Previous Article | Next Article ![]()
Infection and Immunity, September 2002, p. 4902-4907, Vol. 70, No. 9
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.9.4902-4907.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Edward Mallinckrodt Department of Pediatrics,1 Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110,2 Wyeth-Lederle Vaccines, West Henrietta, New York 145863
Received 1 March 2002/ Returned for modification 2 April 2002/ Accepted 4 June 2002
|
|
|---|
|
|
|---|
Haemophilus influenzae is a gram-negative bacterium that is often found as a commensal inhabitant of the respiratory tract in healthy adults but also represents a common cause of both localized respiratory tract and invasive systemic disease (25). In studies examining interactions between H. influenzae clinical isolates and human respiratory tract tissue, bacteria were often associated with damaged epithelium and exposed ECM (16, 17). Furthermore, examination of bronchial biopsies from patients with persistent H. influenzae bronchitis revealed organisms in the subepithelial compartment, suggesting that this pathogen is capable of penetrating the basement membrane (11). Additional analysis of interactions between clinical isolates and purified ECM components demonstrated that many H. influenzae strains were capable of binding to fibronectin, laminin, and various collagens (2, 27). In recent work, Virkola and coworkers found that H. influenzae hemagglutinating pili mediated attachment to both fibronectin and heparin-binding growth-associated molecule, although nonpiliated strains were also capable of binding to these proteins (26).
In addition to producing pili, H. influenzae elaborates numerous nonpilus adhesins. One of these adhesins, called Hap, is ubiquitous among both nontypeable (nonencapsulated) and type b encapsulated clinical isolates and promotes binding to a variety of cultured human epithelial cells (20). Hap is a member of the autotransporter family of gram-negative bacterial virulence factors (7). In recent work, we demonstrated that the Hap autotransporter consists of an amino-terminal signal sequence that directs transport across the bacterial inner membrane, a 110-kDa adhesive passenger domain called Haps, and a 45-kDa translocator domain called Hapß (8). As with other autotransporters, the translocator domain is thought to insert itself into the outer membrane as a pore-forming beta-barrel through which the adhesive passenger domain is extruded to reach the bacterial cell surface. In addition to its adhesive activity, the Haps passenger domain also harbors serine protease activity that directs autoproteolytic cleavage of Haps from Hapß under certain circumstances. Mutation of the Haps active-site serine residue at position 243 to an alanine (HapS243A) inhibits release of Haps from the bacterial surface and results in increased adherence to epithelial cells.
In the present study, we sought to determine whether Hap is capable of interacting with ECM proteins. In initial experiments, we found that Hap promotes attachment of bacteria to purified fibronectin, laminin, and collagen IV. In addition, we observed that purified Haps passenger domain binds with high affinity to these ECM proteins and that Haps interacts specifically with the 45-kDa gelatin-binding domain of fibronectin. These results provide additional insight into the mechanisms by which H. influenzae colonizes the human respiratory tract.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
Quantitative adherence assays. Adherence assays were performed as described previously (21). Twenty-four-well tissue culture plates coated with human plasma fibronectin, murine laminin, or murine collagen IV (BD Biosciences) were rehydrated in 0.5 ml of minimum essential medium (Sigma), and plates were warmed to 37°C for 1 h in a tissue culture incubator infused with 5% CO2. Percent adherence was calculated by dividing the number of adherent CFU per well by the number of inoculated CFU.
Far-Western dot immunoblots. Purified human plasma fibronectin, murine laminin, and murine collagen IV were obtained from BD Biosciences. Fibronectin fragments and bovine serum albumin (BSA) were obtained from Sigma. Haps was purified as described previously (8). ECM proteins were spotted in 50-µg quantities into wells of a 96-well dot blot manifold apparatus holding a nitrocellulose membrane. Samples were incubated for 30 min and then pulled through the membrane by vacuum suction. Subsequently, the membrane was blocked in Tris-buffered saline plus 5% skim milk for 1 h. The membrane was then incubated with purified Haps diluted to a final concentration of 10 µg/ml in Tris-buffered saline plus 5% skim milk. Next, the membrane was incubated with anti-Haps antiserum RabK2 (9) diluted 1:1,000 and then a secondary anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase (Sigma) diluted 1:10,000. Detection of Haps binding was accomplished by incubating the membrane in a chemiluminescent horseradish peroxidase substrate solution (Pierce, Rockford, Ill.) and exposing the membrane to film.
Enzyme-linked immunosorbent assays (ELISAs). Collagen II-coated 96-well plates were prepared using purified bovine tracheal collagen II (Sigma) and a protocol provided by the manufacturer. In particular, collagen II was dissolved in ice-cold 0.5 M acetic acid, pH 2.0, to a final concentration of 1 mg/ml. Wells of tissue culture-treated 96-well plates (Costar) were incubated with 40 µl of dissolved collagen at room temperature for 1 h with gentle shaking and were then washed once with PBS. In control plates, coating was confirmed using mouse ascites fluid against collagen II (Sigma), a secondary anti-mouse antibody conjugated to horseradish peroxidase, and a chromogenic horseradish peroxidase substrate (Kirkegaard & Perry Laboratories, Gaithersburg, Md.), followed by measurement of absorbance at 650 nm. Ninety-six-well plates coated with fibronectin, laminin, and collagen IV were obtained from BD Biosciences.
Wells were blocked with 200 µl of PBS-1% BSA for 1 h at room temperature and then washed once with PBS. One hundred microliters of purified Haps or purified HifB (22) diluted in PBS plus 1% BSA to final concentrations of 0.5, 1, 5, 10, 50, or 100 nM was added to triplicate wells, and plates were incubated for 1 h at room temperature. Wells were then incubated successively for 1 h with anti-Haps antiserum RabK2 or anti-HifB antiserum Rab452 (22), each diluted 1:1,000 in PBS-1% BSA, and then a secondary anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase diluted 1:10,000 in PBS-1% BSA. Wells were washed three times with PBS after each incubation step. After the final wash, binding by Haps or HifB binding was detected by incubating wells with 200 µl of a chromogenic horseradish peroxidase substrate (Kirkegaard & Perry Laboratories) and measurement of absorbance at 650 nm. Data were analyzed using PadPrism software (version 3.0a).
|
|
|---|
![]() View larger version (159K): [in a new window] |
FIG. 1. SEM of H. influenzae strains DB117/pGJB103 and DB117/pHapS243A after incubation with ECM proteins. Shown are representative fields of SEM samples with DB117 expressing empty vector (top panels) or HapS243A (bottom panels). Suspensions of bacteria were incubated with glass slides previously coated with purified fibronectin (A and D), laminin (B and E), or collagen IV (C and F). Bars correspond to 10 µm.
|
![]() View larger version (30K): [in a new window] |
FIG. 2. Adherence to ECM proteins by H. influenzae strain DB117 expressing wild-type Hap or HapS243A and inhibition of adherence by anti-Haps antiserum. Adherence to fibronectin, laminin, and collagen IV was calculated by dividing the number of adherent bacteria by the number of inoculated bacteria. Error bars represent the mean ± standard error of the mean of measurements made in triplicate from representative experiments. Adherence was inhibited by increasing concentrations of antiserum RabK2, which reacts with Haps. A 1:100 dilution of preimmune rabbit serum had no effect on adherence. The x axis varies from one panel to the next.
|
Beyond being present in plasma and ECM, fibronectin is associated with the surface of epithelial cells. Accordingly, we wondered whether fibronectin might serve as a receptor in interactions between bacteria expressing Hap and cultured epithelial cells. To explore this possibility, we preincubated confluent monolayers of Chang or A549 epithelial cells with various dilutions of a polyclonal antiserum directed against fibronectin (Sigma) and then inoculated DB117 expressing HapS243A. In uninfected control samples, fluorescence microscopy confirmed antibody binding to cells as large aggregates, suggesting clumps of fibronectin (data not shown). In samples inoculated with DB117/pHapS243A, even with the highest concentration of antifibronectin antiserum, we observed no reduction in adherence (data not shown), suggesting that fibronectin is probably not the receptor for Hap on epithelial cells. Alternatively, cellular fibronectin may be one of several receptors present in quantities large enough that blockage of fibronectin does not interfere with overall adherence levels.
Purified Haps binds to purified fibronectin, laminin, and collagen IV. To extend our observations with bacteria expressing Hap, we examined whether purified Haps (the Hap adhesive domain) could interact with fibronectin, laminin, and collagen IV in protein binding assays. Initially, 50-µg samples of these ECM proteins were immobilized on a nitrocellulose membrane, which was then overlaid with purified Haps diluted to a final concentration of 10 µg/ml. As shown in Fig. 3, far-Western immunoblot assays demonstrated binding of Haps to fibronectin, laminin, and collagen IV. No binding of Haps was detected to a control spot containing 50 µg of BSA. Since many fibronectin-binding proteins are known to interact with specific domains of fibronectin, we prepared two additional spots containing purified fibronectin proteolytic fragments (Sigma), one representing the 30-kDa heparin-binding domain and the other representing the 45-kDa gelatin-binding domain. In this experiment, Haps bound to the 45-kDa fragment but not the 30-kDa fragment, suggesting that Hap interacts specifically with the fibronectin gelatin-binding region (Fig. 3).
![]() View larger version (32K): [in a new window] |
FIG. 3. Far-Western dot immunoblot of purified Haps binding to ECM proteins. Samples were loaded with 50 µg of purified protein as follows: lane 1, BSA; lane 2, fibronectin; lane 3, fibronectin 30-kDa heparin-binding fragment; lane 4, fibronectin 45-kDa gelatin-binding fragment; lane 5, laminin; lane 6, collagen IV. Immunoblotting was performed with antiserum RabK2 after incubation of the membrane with purified Haps diluted to 10 µg/ml.
|
![]() View larger version (25K): [in a new window] |
FIG. 4. Dose-dependent binding of purified Haps to ECM proteins. Shown are results of binding of increasing concentrations of purified Haps to fibronectin, collagen IV, laminin, and collagen II by purified Haps. Binding was quantitated by ELISA at an absorbance of 650 nm. Points represent the means (error bars, standard errors of the means) of measurements made in triplicate. Binding curves were calculated by nonlinear regression analysis using GraphPad Prism software (version 3.0).
|
|
|
|---|
Inhibition of Hap-mediated adherence to fibronectin, laminin, and collagen IV by antiserum RabK2 provides further evidence for the presence of ECM binding domains within Haps. RabK2 reacts specifically with epitopes in Haps and does not react with the Hapß translocator domain. It is possible that some antibodies in RabK2 react with the C terminus of Haps and obscure a binding domain in the N terminus of Hapß. However, a binding domain in Hapß would presumably be equally abundant on bacteria expressing either wild-type Hap or HapS243A. The difference in adherence efficiencies between DB117/pJS106 and DB117/pHapS243A argues against this possibility. Studies with Hap in-frame deletion mutants have focused our search for ECM binding domains on the C-terminal half of Haps (D. L. Fink and J. W. St. Geme III, unpublished observations), and scanning mutagenesis within this region may eventually pinpoint individual residues involved in binding domains.
Examination of interactions between Haps and fibronectin fragments suggests that Hap may interact specifically with the 45-kDa gelatin-binding domain of fibronectin. These data do not exclude the possibility of interactions between Hap and other fibronectin domains, which remain to be evaluated. Successful mapping of fibronectin binding domains has been achieved for certain bacterial adhesins by far-Western immunoblot of fibronectin fragments produced by limited proteolysis with thermolysin (Magnus Höök, personal communication). This strategy has so far been unsuccessful with purified Haps, further suggesting that Hap may recognize a conformational epitope on natively folded fibronectin. Future studies will evaluate interactions between Haps and purified thermolysin-digested fibronectin fragments.
Our results demonstrate that Hap promotes adherence to three distinct ECM proteins. Similar broad-spectrum binding profiles have been reported for several other bacterial adhesins, including FnbpA and Emp of Staphylococcus aureus, Ace of Enterococcus faecalis, and YadA of Yersinia spp. (4, 10, 13). Purified Haps binds to fibronectin, laminin, and collagen IV with comparably high affinities in ELISAs, suggesting that Hap may interact with a particular structural epitope present on all three proteins. Candidates for this type of receptor structure include complex sugars of glycosylated proteins, as is the case with binding of H. influenzae pili and the HMW1 adhesin to their respective receptors. However, preliminary studies with chemical or enzymatic disruption of carbohydrate structures on fibronectin and laminin indicate that sugars may not be involved in interactions between Hap and ECM proteins. Hap may instead recognize a protein fold common among fibronectin, laminin, and collagen IV. Curiously, the binding constants for interactions between purified Haps and ECM proteins are also similar to those calculated for binding of Haps to Chang and A549 epithelial cells (Fink et al., submitted for publication), raising the possibility that an ECM protein may be the cellular receptor for Hap. Although pretreatment of cells with antifibronectin antibodies does not affect Hap-mediated bacterial adherence, any of a number of cell-associated ECM proteins could potentially serve as a receptor. Alternatively, the cellular Hap receptor may possess a conformational epitope similar to those present in ECM proteins.
In considering the role of Hap in NTHI colonization of the respiratory tract, it is noteworthy that fibronectin, laminin, and collagen IV are all components of basement membrane underlying respiratory epithelium. Additionally, fibronectin is present on the surface of epithelial cells. In contrast to the situation with collagen IV, Haps does not bind to collagen II, which is found mainly in cartilage and would not typically be encountered by H. influenzae during natural infection. NTHI disease is often associated with underlying chronic obstructive pulmonary disease or recent respiratory viral infection (6, 12, 15). Given that respiratory inflammation involves increased production of fibronectin and collagen and deposition of these proteins on epithelial cells (18), Hap-mediated bacterial attachment to ECM may be an important factor in initial colonization of the inflamed respiratory tract as well as contiguous spread of organisms to new sites of infection. Furthermore, damaged epithelium and exposed basement membrane are often found in the context of respiratory tract inflammation. NTHI associates preferentially with damaged epithelium in studies with nasopharyngeal tissue and explants from persistently infected patients (11, 16), and Hap may contribute to these interactions.
In summary, the H. influenzae Hap adhesin promotes bacterial adherence to fibronectin, laminin, and collagen IV. Retention of the Haps passenger domain on the bacterial cell surface enhances adherence to these ECM proteins, while treatment with an antiserum reactive against Haps inhibits adherence. In assays with purified proteins, Haps binds with high affinity to fibronectin, laminin, and collagen IV. Purified Haps interacts specifically with the 45-kDa gelatin-binding domain of fibronectin and not with the 30-kDa heparin-binding domain. These data suggest a possible mechanism for previously observed interactions between nontypeable H. influenzae and ECM and further advocate that these interactions may be important to colonization of the respiratory tract by NTHI. Future studies will seek to identify the Haps binding domains responsible for adherence to ECM proteins and their cognate receptor sites on fibronectin, laminin, and collagen IV.
We thank Jerry Pinkner for valuable assistance in the purification of Haps; Rob Smith for his assistance with electron microscopy; and Dave Cutter, Sue Grass, and Sven Laarmann for technical help.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»